![Xin Wei Wang Profile](https://pbs.twimg.com/profile_images/468789062464065537/YJRvTapQ_x96.jpeg)
Xin Wei Wang
@XinWang77
Followers
547
Following
472
Statuses
303
Senior Investigator at the National Cancer Institute with a special interest in basic and translational cancer research. Tweets and opinions are my own.
Rockville
Joined March 2014
RT @NatureMedicine: Implementing equitable, sustainable remote patient monitoring will ensure that #diabetes tech is accessible — but we ne…
0
3
0
Congrats Andre and the team!
A high-resolution view of how replication-coupled DNA breaks are generated, processed and repaired. Congrats to @pavani_raphael, @TripathiVeenu, and many terrific collaborators including @FrogWalterLab, @CejkaLab, @weiwsmiling. See
0
0
0
RT @EricTopol: The problem with our cancer immunotherapy is that it needs to be JAK-ed up, made stronger. Two new reports in lymphoma and l…
0
64
0
So thrilled to have spent the day discussing liver cancer research from @NCIResearchCtr, and listening to many exciting projects from wonderful colleagues #HormelInstitute. Enjoyed an afternoon break to celebrate Dr. Gradlone’s promotion to Professor. Congratulations, Sergio!
Great visit and fantastic talk today by Dr. Xin Wei Wang @XinWang77 at The Hormel Institute #LiverCancer risk factors. @UMNCancer @UMNresearch @UMN_DOMResearch
0
0
15
Congratulations Dr. Ryan!
Very excited to announce I matched at @OhioStateSurg for Surgical Oncology. Huge thanks to all of mentors, and especially everyone @NCI_SurgOncFel and @UBSurgery
0
0
2
Agree! A clear cut robust result does not require much statistical value such as p<0.05 to support. It will be good to know if pathological response is supported by an overall survival.
Neoadjuvant nivolumab plus ipilimumab results in a substantial pathological response in most patients with mismatch repair–deficient colon cancer and appears to be safe. Read the full NICHE-2 phase 2 study results:
0
0
7
What an incredible science talk by Dr. Putatunda @VPutatunda @NCIResearchCtr @NCICCR_SurgOnc today. I learned so much from him about mechanisms of immunotherapy response, and his passion towards science. He is becoming a great physician scientist. Congrats!
0
2
22
RT @BudhuLCP: Join #NCICCRLiverProgram seminar on Thursday, May 16, 2024 at 1PM EST. @NCIResearchCtr
0
1
0
My fellow put a cartoon by @AlexanderDent6 on my office door @NCIResearchCtr one day, which prompted me to reflect on the type of mentors we are and aspire to become. Deep inside, we all aspire to become better mentors/PIs.
1
5
13
Global cancer health and disparity research are major focuses of the CCR Laboratory of Human Carcinogenesis @NCIResearchCtr. We look forward for a productive collaboration with the Kenya team under the leadership of @FrancisMakokha3.
I thoroughly enjoyed learning how PhIPSeq and VirScan can be used to detect persons at high risk of hepatocellular carcinoma from @XinWang77 team. Committed to a working collaboration ASAP. @Nyuka_Bel @KinyoriG @Wahura1 @ChemtaiMungo @BendaKithaka @DrEliasMelly @NCIKenya
1
4
22
RT @EricTopol: On the link between engineered T-cells (CAR T) and secondary cancers: ~30 cases reported among 30,000 people treated https:…
0
106
0
RT @TheLancet: The use of artificial intelligence (AI) in health care has seen remarkable growth in the past 5 years. A new Review from @…
0
205
0
RT @Nature: This study challenges the idea that cancer is caused only by permanent changes to DNA
0
256
0
So proud of Theressa Ewa @NIHOxCam @NCIResearchCtr who just won the Outstanding Poster Award on last Friday presented by @NCIDrDougLowy for her PhD project on cancer health disparity in HCC mentored by @WhitneyLeet1 . Congrats!
0
3
11
RT @WorldLiverDay: #WorldLiverDay is TODAY! Let's pledge to prioritise our liver's well-being. Whether it's making healthier lifestyle…
0
41
0